Page 63 - Vitamin D and Cancer

50 J. Thorne and M.J. Campbell

148. Wu Y, Craig TA, Lutz WH, Kumar R (1999) Identification of 1 alpha, 25-dihydroxyvitamin
D3 response elements in the human transforming growth factor beta 2 gene. Biochemistry
38:2654–2660
149. Matilainen M, Malinen M, Saavalainen K, Carlberg C (2005) Regulation of multiple insulin-
like growth factor binding protein genes by 1alpha, 25-dihydroxyvitamin D3. Nucleic Acids
Res 33:5521–5532
150. Vousden KH, Lu X (2002) Live or let die: the cell’s response to p53. Nat Rev Cancer
2:594–604
151. Lee D et al (2002) SWI/SNF complex interacts with tumor suppressor p53 and is necessary
for the activation of p53-mediated transcription. J Biol Chem 277:22330–22337
152. Wilkinson DS et al (2005) A direct intersection between p53 and transforming growth factor
beta pathways targets chromatin modification and transcription repression of the alpha-
fetoprotein gene. Mol Cell Biol 25:1200–1212
153. Szeto FL et al (2007) Involvement of the vitamin D receptor in the regulation of NF-[kappa]
B activity in fibroblasts. J Steroid Biochem Mol Biol 103:563–566
154. Froicu M, Cantorna M (2007) Vitamin D and the vitamin D receptor are critical for control
of the innate immune response to colonic injury. BMC Immunol 8:5
155. Gombart AF, Borregaard N, Koeffler HP (2005) Human cathelicidin antimicrobial peptide
(CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in
myeloid cells by 1, 25-dihydroxyvitamin D3. FASEB J 19:1067–1077
156. Wan T-T et al (2004) Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimi-
crobial peptide gene expression. J Immunol 173:2909–2912
157. Mallbris LED, Sundblad L, Granath F, Stahle M (2005) UVB Upregulates the antimicrobial
protein hCAP18 mRNA in human skin. J Investig Dermatol 125:1072–1074
158. Zasloff M (2005) Sunlight, vitamin D, and the innate immune defenses of the human skin. J
Investig Dermatol 125:xvi–xvii
159. Quigley DA et al (2009) Genetic architecture of mouse skin inflammation and tumour sus-
ceptibility. Nature 458(7237):505–8
160. Blutt SE, McDonnell TJ, Polek TC, Weigel NL (2000) Calcitriol-induced apoptosis in
LNCaP cells is blocked by overexpression of Bcl-2. Endocrinology 141:10–17
161. Mathiasen I, Lademann U, Jaattela M (1999) Apoptosis induced by vitamin D compounds
in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
Cancer Res 59:4848–4856
162. Song H et al (2003) Vitamin D(3) up-regulating protein 1 (VDUP1) antisense DNA regulates
tumorigenicity and melanogenesis of murine melanoma cells via regulating the expression
of fas ligand and reactive oxygen species. Immunol Lett 86:235–247
163. Han SH et al (2003) VDUP1 upregulated by TGF-beta1 and 1, 25-dihydorxyvitamin D3
inhibits tumor cell growth by blocking cell-cycle progression. Oncogene
22:4035–4046
164. Albertson DG et al (2000) Quantitative mapping of amplicon structure by array CGH
identifies CYP24 as a candidate oncogene. Nat Genet 25:144–146
165. Townsend K et al (2005) Autocrine metabolism of vitamin D in normal and malignant breast
tissue. Clin Cancer Res 11:3579–3586
166. Abedin SA et al (2009) Elevated NCOR1 disrupts a network of dietary-sensing nuclear
receptors in bladder cancer cells. Carcinogenesis 30(3):449–56
167. Menezes RJ et al (2008) Vitamin D receptor expression in normal, premalignant, and
malignant human lung tissue. Cancer Epidemiol Biomarkers Prev 17:1104–1110
168. Pendas-Franco N et al (2008) DICKKOPF-4 is induced by TCF/beta-catenin and upregu-
lated in human colon cancer, promotes tumour cell invasion and angiogenesis and is
repressed by 1alpha, 25-dihydroxyvitamin D3. Oncogene 27:4467–4477
169. Palmer HG et al (2004) The transcription factor SNAIL represses vitamin D receptor
expression and responsiveness in human colon cancer. Nat Med 10:917–919
170. Palmer HG et al (2001) Vitamin D(3) promotes the differentiation of colon carcinoma cells by
the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154:369–387